Fountain Healthcare Partners
Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.
📥 Buy Full VC Dataset
Offices: Dublin (Ireland), New York (United States)
Investment Stages: Seed, Series A, Series B
Markets: Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics
Founded Year: 2008
Investor Type: Venture Capital
Portfolio Companies: Inotrem, Mainstay Medical (MSTY), Calypso Biotech, Ermium Therapeutics, Priothera, XyloCor Therapeutics, Corteria Pharmaceuticals, Dualyx, Chrono, Innocoll, Neuromod, Inflazome, NeRRe Therapeutics, Velicept, KaNDy Therapeutics, Medical Microinstruments S.r.l. (MMI), Syndesi Therapeutics, Neurent Medical, Amarin, Civitas, Genable, Neuravi, Opsona, Vivasure Medical, Cappella/ArraVasc Limited, Trino Therapeutics, Palyon Medical
Website: https://www.fh-partners.com
Team Page: https://www.fh-partners.com/team
Portfolio Link: https://www.fh-partners.com/portfolio
LinkedIn: https://www.linkedin.com/company/fountain-healthcare-partners
Crunchbase: https://www.crunchbase.com/organization/fountain-healthcare-partners
Comments
No comments yet. Be the first to comment!